Dr. Weiner on the Criteria Required to Become an NCI-Designated Cancer Center

Louis M. Weiner, MD
Published: Friday, May 10, 2019



Louis M. Weiner, MD, director of the Georgetown Lombardi Comprehensive Cancer Center, discusses the criteria required to become an NCI-designated cancer center.

In order to achieve NCI designation, a cancer center has to be innovative and demonstrate a capacity to conduct clinical meaningful and high-quality translational research. Translational research is a critical component of NCI-designated comprehensive cancer centers, says Weiner. Moreover, these institutions have to have strong programs in place with regard to screening and treatment. They also have to be willing to take center stage, promote awareness, and assure that patients are receiving appropriate therapy, he adds. Community outreach and engagement is an integral piece of this.

Cancer career research enhancement and educational activities are another integral layer of such a designation, explains Weiner. This ensures that the next generation of providers and researchers are equipped with the proper tools to further cancer discovery. It is an arduous, but rewarding process, Weiner concludes.
SELECTED
LANGUAGE


Louis M. Weiner, MD, director of the Georgetown Lombardi Comprehensive Cancer Center, discusses the criteria required to become an NCI-designated cancer center.

In order to achieve NCI designation, a cancer center has to be innovative and demonstrate a capacity to conduct clinical meaningful and high-quality translational research. Translational research is a critical component of NCI-designated comprehensive cancer centers, says Weiner. Moreover, these institutions have to have strong programs in place with regard to screening and treatment. They also have to be willing to take center stage, promote awareness, and assure that patients are receiving appropriate therapy, he adds. Community outreach and engagement is an integral piece of this.

Cancer career research enhancement and educational activities are another integral layer of such a designation, explains Weiner. This ensures that the next generation of providers and researchers are equipped with the proper tools to further cancer discovery. It is an arduous, but rewarding process, Weiner concludes.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication
x